BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND HERPUD1, ENSG00000051108, 9709, Q15011, SUP, Mif1, KIAA0025, HERP
11 results:

  • 1. herpud1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways.
    Nie X; Liu D; Zheng M; Li X; Liu O; Guo Q; Zhu L; Lin B
    BMC Cancer; 2022 Dec; 22(1):1338. PubMed ID: 36544104
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. superficial Peritoneal Endometriosis: Clinical Characteristics of 203 Confirmed Cases and 1292 Endometriosis-Free Controls.
    Reis FM; Santulli P; Marcellin L; Borghese B; Lafay-Pillet MC; Chapron C
    Reprod Sci; 2020 Jan; 27(1):309-315. PubMed ID: 32046376
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Definition, description, clinicopathological features, pathogenesis and natural history of endometriosis: CNGOF-HAS Endometriosis Guidelines].
    Borghese B; Santulli P; Marcellin L; Chapron C
    Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):156-167. PubMed ID: 29540335
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes.
    Chapron C; Tosti C; Marcellin L; Bourdon M; Lafay-Pillet MC; Millischer AE; Streuli I; Borghese B; Petraglia F; Santulli P
    Hum Reprod; 2017 Jul; 32(7):1393-1401. PubMed ID: 28510724
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Serum Osteopontin Levels Are Decreased in Focal Adenomyosis.
    Streuli I; Santulli P; Chouzenoux S; Chapron C; Batteux F
    Reprod Sci; 2017 May; 24(5):773-782. PubMed ID: 27678100
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A sup-score test for the cure fraction in mixture models for long-term survivors.
    Hsu WW; Todem D; Kim K
    Biometrics; 2016 Dec; 72(4):1348-1357. PubMed ID: 27078815
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Soluble ligands for the NKG2D receptor are released during endometriosis and correlate with disease severity.
    González-Foruria I; Santulli P; Chouzenoux S; Carmona F; Batteux F; Chapron C
    PLoS One; 2015; 10(3):e0119961. PubMed ID: 25775242
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of susceptibility genes for peritoneal, ovarian, and deep infiltrating endometriosis using a pooled sample-based genome-wide association study.
    Borghese B; Tost J; de Surville M; Busato F; Letourneur F; Mondon F; Vaiman D; Chapron C
    Biomed Res Int; 2015; 2015():461024. PubMed ID: 25722978
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of candidate serologic markers for type I and type II ovarian cancer.
    Lu D; Kuhn E; Bristow RE; Giuntoli RL; Kjær SK; Shih IeM; Roden RB
    Gynecol Oncol; 2011 Sep; 122(3):560-6. PubMed ID: 21704359
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A qualitative analysis of social concerns of women with ovarian cancer.
    Ferrell BR; Smith SL; Ervin KS; Itano J; Melancon C
    Psychooncology; 2003; 12(7):647-63. PubMed ID: 14502590
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function.
    Shin BK; Wang H; Yim AM; Le Naour F; Brichory F; Jang JH; Zhao R; Puravs E; Tra J; Michael CW; Misek DE; Hanash SM
    J Biol Chem; 2003 Feb; 278(9):7607-16. PubMed ID: 12493773
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.